Neuropsychology of Cardiovascular Disease 2nd Edition
Edited by Shari R. Waldstein, Merrill F. Elias
Psychology Press – 2015 – 560 pages
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States and most westernized nations. Both CVDs and their risk factors confer substantial risk for stroke and dementia, but are also associated with more subtle changes in brain structure and function and cognitive performance prior to such devastating clinical outcomes. It has been suggested that there exists a continuum of brain abnormalities and cognitive difficulties associated with increasingly severe manifestations of cardiovascular risk factors and diseases that precede vascular cognitive impairment and may ultimately culminate in stroke or dementia.
This second edition examines the relations of a host of behavioral and biomedical risk factors, in addition to subclinical and clinical CVDs, to brain and cognitive function. Associations with dementia and pre-dementia cognitive performance are reported, described, and discussed with a focus on underlying brain mechanisms. Future research agendas are suggested, and clinical implications are considered. The volume is a resource for professionals and students in neuropsychology, behavioral medicine, neurology, cardiology, cardiovascular and behavioral epidemiology, gerontology, geriatric medicine, nursing, adult developmental psychology, and for other physicians and health care professionals who work with patients with, or at risk for, CVDs.
Part I: Behavioral and Biomedical Risk Factcors
1. The Effects of Tobacco Smoke on Cognition and the Brain, Gary E. Swan. and Christina N. Lessov-Schlagger
2. Alcohol Consumption, Brain, and Neurocognition, Francesco Panza, Vincenza Frisardi, Davide Seripa, Alberto Pilotto, and Vincenzo Solfrizzi
3. Activity and Neurocognitive Health in Older Adults, Michelle C. Carlson and Vijay R. Varma
4. Hypertension, Blood Pressure, and Cognitive Functioning, Merrill F. Elias, Amanda F. Goodell, and Michael A. Robbins
5. Effects of Cholesterol and N-3 Fatty Acids on Cognitive Functioning, Decline, and Dementia, Matthew F. Muldoon and Sarah M. Conklin
6. Cognition in Diabetes and Pre-Diabetes Stages, Augustina M.A. Brands, Esther van den Berg, Geert Jan, Biessels ,and Roy P.C. Kessels
7. Neurocognitive Aspects of Obesity, Kelly M. Stanek, Lindsay A. Miller, and John Gunstad.
8. Inflammation, Anna L. Marsland
9. Homocysteine, Folic Acid, B Vitamins, and Cognitive Functioning, Georgina E. Crichton, Michael A. Robbins, and Merrill, F. Elias
10. Resting and Stress-Reactive Cortisol, Nida Ali, Vincent Corbo, Laura Copeland, & Jens C. Pruessner
Part II: Cardiovascular Disease and Interventions
11. Subclinical Cardiovascular Disease and Neurocognition, Carrington Rice Wendell, and Shari R. Waldstein
12. Clinical Cardiovascular Disease, Nathalie Stroobant, Merrill, F. Elias, and Amanda F. Goodell,
13. Coronary Artery Bypass Surgery, Patrick J. Smith, Joseph P. Mathew, and James A. Blumenthal, Ph.D.
14. Heart Failure and Cognitive Function, Ronald A. Cohen and Karin F. Hoth
Part III: Dementia & Stroke
15. Cardiovascular Risk Factors and Dementia, Chengxuan Qiu and Laura Fratiglioni
16. Vascular Cognitive Impairment, Jose G. Merino and Vladimir Hachinski
17. White Matter Disease, Stroke, and the Heterogeneity of Vascular Dementia, Catherine C. Price, Peter Nguyen, Melissa Lamar, and David J. Libon
18. Structural Brain Mechanisms and Dementia, Samuel N. Lockhart and Charles DeCarli
Shari R. Waldstein, PhD is Professor of Psychology, Gerontology, and Medicine at the University of Maryland, Baltimore County and University of Maryland School of Medicine.
Merrill F. Elias, PhD, MPH, FAHA is Professor of Psychology and Cooperating Professor, Graduate School of Biomedical Science and Engineering at the University of Maine.